Drug Discovery Clinical Trial Clinical Development

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1831683

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1831683

Neurology Clinical Trials Market Size, Share, Trends, Industry Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design, By Indication, By Value Chain, By Region - Market Forecast, 2025-2034

PUBLISHED: September 1, 2025

PAGES: 125 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The global neurology clinical trials market size is expected to reach USD 10.59 billion by 2034, according to a new study by Polaris Market Research. The report "Neurology Clinical Trials Market Size, Share, Trends, Industry Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design, By Indication, By Value Chain, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The neurology clinical trials market involves the research and development of new drugs, therapies, and medical devices designed to treat conditions of the nervous system. This includes a wide range of diseases and disorders affecting the brain, spinal cord, and peripheral nerves, such as Alzheimer's, Parkinson's, epilepsy, and stroke. The main goal of these trials is to test the safety and effectiveness of new treatments, providing the necessary data for regulatory approval so that new therapies can become available to the public.

The market's growth is largely driven by the increasing number of people worldwide who are affected by neurological disorders, along with clinical trial technology and services. This rising disease burden, combined with the often limited or ineffective treatment options for many conditions, creates a strong demand for new therapies. As a result, there is a lot of research and development happening, supported by growing investments from both private and public sectors. The market's overview shows that it is a complex and competitive field, with a focus on both traditional drug development and newer, more specialized treatments like gene therapies and personalized medicine.

Neurology Clinical Trials Market Report Highlights:

By phase, the phase III segment held the largest share of the neurology clinical trials market in 2024 as these trials are the final and most extensive step before a drug can be submitted for regulatory approval.

By study design, the interventional studies segment held the largest share in 2024. This is due to the fact that these trials are the standard method for testing new drugs and medical devices, as they involve giving a specific treatment to participants and directly measuring its effects.

By indication, the Alzheimer's disease segment held the largest share in 2024. This is because of the large number of people affected by this condition and the urgent global need for effective treatments.

By value chain, the in-house segment held the largest share in 2024 of the market. Many large pharmaceutical and biotech companies have the internal resources, expertise, and funding to manage their entire clinical trial process themselves, giving them full control and ensuring the quality of their research.

By region, North America held the largest share of the neurology clinical trials market in 2024. This is due to its well-developed healthcare system, a high concentration of key pharmaceutical and biotechnology companies, and a significant amount of research and development funding for neurological disorders. The Asia Pacific is a rapidly growing market for neurology clinical trials. The region's growth is driven by its large and diverse patient population, which makes patient recruitment for trials more efficient and cost-effective.

A few key players in the market include IQVIA, ICON plc, Syneos Health, Laboratory Corporation of America Holdings, Charles River Laboratories, Thermo Fisher Scientific, Parexel, Medpace Holdings, and pharmaceutical companies like Pfizer, Biogen, and Eisai Co.

Polaris Market Research has segmented the neurology clinical trials market report based on phase, study design, indication, value chain, and region:

By Phase Outlook (Revenue - USD Billion, 2020-2034)

Phase I

Phase II

Phase III

Phase IV

By Study Design Outlook (Revenue - USD Billion, 2020-2034)

Interventional

Observational

Expanded Access

By Indication Outlook (Revenue - USD Billion, 2020-2034)

Alzheimer's Disease

Depression (MDD)

Parkinson's Disease (PD)

Epilepsy

Stroke

Traumatic Brain Injury (TBI)

Amyotrophic Lateral Sclerosis (ALS)

Huntington's Disease

Muscle Regeneration

Others

By Value Chain Outlook (Revenue - USD Billion, 2020-2034)

In-house

CROs

Investigator Sites/Clinical Sites

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Product Code: PM6420

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Neurology Clinical Trials Market Insights

4.1. Neurology Clinical Trials Market - Market Snapshot
4.2. Neurology Clinical Trials Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Prevalence of Neurological Disorders
  - 4.2.1.2. Increase in Government Funding and Support
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High trial failure rates due to the complexity
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Neurology Clinical Trials Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Neurology Clinical Trials Market, by Phase

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
5.3. Phase I
- 5.3.1. Global Neurology Clinical Trials Market, by Phase I, by Region, 2020-2034 (USD Billion)
5.4. Phase II
- 5.4.1. Global Neurology Clinical Trials Market, by Phase II, by Region, 2020-2034 (USD Billion)
5.5. Phase III
- 5.5.1. Global Neurology Clinical Trials Market, by Phase III, by Region, 2020-2034 (USD Billion)
5.6. Phase IV
- 5.6.1. Global Neurology Clinical Trials Market, by Phase IV, by Region, 2020-2034 (USD Billion)

6. Global Neurology Clinical Trials Market, by Study Design

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
6.3. Interventional
- 6.3.1. Global Neurology Clinical Trials Market, by Interventional, by Region, 2020-2034 (USD Billion)
6.4. Observational
- 6.4.1. Global Neurology Clinical Trials Market, by Observational, by Region, 2020-2034 (USD Billion)
6.5. Expanded Access
- 6.5.1. Global Neurology Clinical Trials Market, by Expanded Access, by Region, 2020-2034 (USD Billion)

7. Global Neurology Clinical Trials Market, by Indication

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
7.3. Alzheimer's Disease
- 7.3.1. Global Neurology Clinical Trials Market, by Alzheimer's Disease, by Region, 2020-2034 (USD Billion)
7.4. Depression (MDD)
- 7.4.1. Global Neurology Clinical Trials Market, by Depression (MDD), by Region, 2020-2034 (USD Billion)
7.5. Parkinson's Disease (PD)
- 7.5.1. Global Neurology Clinical Trials Market, by Parkinson's Disease (PD), by Region, 2020-2034 (USD Billion)
7.6. Epilepsy
- 7.6.1. Global Neurology Clinical Trials Market, by Epilepsy, by Region, 2020-2034 (USD Billion)
7.7. Stroke
- 7.7.1. Global Neurology Clinical Trials Market, by Stroke, by Region, 2020-2034 (USD Billion)
7.8. Traumatic Brain Injury (TBI)
- 7.8.1. Global Neurology Clinical Trials Market, by Traumatic Brain Injury (TBI), by Region, 2020-2034 (USD Billion)
7.9. Amyotrophic Lateral Sclerosis (ALS)
- 7.9.1. Global Neurology Clinical Trials Market, by Amyotrophic Lateral Sclerosis (ALS), by Region, 2020-2034 (USD Billion)
7.10. Huntington's Disease
- 7.10.1. Global Neurology Clinical Trials Market, by Huntington's Disease, by Region, 2020-2034 (USD Billion)
7.11. Muscle Regeneration
- 7.11.1. Global Neurology Clinical Trials Market, by Muscle Regeneration, by Region, 2020-2034 (USD Billion)
7.12. Others
- 7.12.1. Global Neurology Clinical Trials Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Neurology Clinical Trials Market, by Value Chain

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
8.3. In-house
- 8.3.1. Global Neurology Clinical Trials Market, by In-house, by Region, 2020-2034 (USD Billion)
8.4. CROs
- 8.4.1. Global Neurology Clinical Trials Market, by CROs, by Region, 2020-2034 (USD Billion)
8.5. Investigator Sites/Clinical Sites
- 8.5.1. Global Neurology Clinical Trials Market, by Investigator Sites/Clinical Sites, by Region, 2020-2034 (USD Billion)

9. Global Neurology Clinical Trials Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. Neurology Clinical Trials Market Assessment, By Geography, 2020-2034 (USD Billion)
9.3. Neurology Clinical Trials Market - North America
- 9.3.1. North America: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.3.2. North America: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.3.3. North America: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.3.4. North America: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.3.5. Neurology Clinical Trials Market - US
  - 9.3.5.1. US: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  - 9.3.5.2. US: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
  - 9.3.5.3. US: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  - 9.3.5.4. US: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.3.6. Neurology Clinical Trials Market - Canada
  - 9.3.6.1. Canada: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  - 9.3.6.2. Canada: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
  - 9.3.6.3. Canada: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  - 9.3.6.4. Canada: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
9.4. Neurology Clinical Trials Market - Europe
- 9.4.1. Europe: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.4.2. Europe: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.4.3. Europe: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.4.4. Europe: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.4.5. Neurology Clinical Trials Market - UK
  - 9.4.5.1. UK: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  - 9.4.5.2. UK: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
  - 9.4.5.3. UK: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  - 9.4.5.4. UK: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.4.6. Neurology Clinical Trials Market - France
  - 9.4.6.1. France: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  - 9.4.6.2. France: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
  - 9.4.6.3. France: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  - 9.4.6.4. France: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.4.7. Neurology Clinical Trials Market - Germany
  - 9.4.7.1. Germany: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  - 9.4.7.2. Germany: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
  - 9.4.7.3. Germany: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  - 9.4.7.4. Germany: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.4.8. Neurology Clinical Trials Market - Italy
  - 9.4.8.1. Italy: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  - 9.4.8.2. Italy: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
  - 9.4.8.3. Italy: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  - 9.4.8.4. Italy: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.4.9. Neurology Clinical Trials Market - Spain
  - 9.4.9.1. Spain: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  - 9.4.9.2. Spain: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
  - 9.4.9.3. Spain: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  - 9.4.9.4. Spain: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.4.10. Neurology Clinical Trials Market - Netherlands
  - 9.4.10.1. Netherlands: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  - 9.4.10.2. Netherlands: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
  - 9.4.10.3. Netherlands: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  - 9.4.10.4. Netherlands: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.4.11. Neurology Clinical Trials Market - Russia
  - 9.4.11.1. Russia: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  - 9.4.11.2. Russia: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
  - 9.4.11.3. Russia: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  - 9.4.11.4. Russia: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.4.12. Neurology Clinical Trials Market - Rest of Europe
  - 9.4.12.1. Rest of Europe: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  - 9.4.12.2. Rest of Europe: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
  - 9.4.12.3. Rest of Europe: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  - 9.4.12.4. Rest of Europe: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
9.5. Neurology Clinical Trials Market - Asia Pacific
- 9.5.1. Asia Pacific: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.5.2. Asia Pacific: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.5.3. Asia Pacific: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.5.4. Asia Pacific: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.5.5. Neurology Clinical Trials Market - China
  - 9.5.5.1. China: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  - 9.5.5.2. China: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
  - 9.5.5.3. China: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  - 9.5.5.4. China: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.5.6. Neurology Clinical Trials Market - India
  - 9.5.6.1. India: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  - 9.5.6.2. India: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
  - 9.5.6.3. India: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  - 9.5.6.4. India: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.5.7. Neurology Clinical Trials Market - Malaysia
  - 9.5.7.1. Malaysia: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  - 9.5.7.2. Malaysia: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
  - 9.5.7.3. Malaysia: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  - 9.5.7.4. Malaysia: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.5.8. Neurology Clinical Trials Market - Japan
  - 9.5.8.1. Japan: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  - 9.5.8.2. Japan: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
  - 9.5.8.3. Japan: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  - 9.5.8.4. Japan: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.5.9. Neurology Clinical Trials Market - Indonesia
  - 9.5.9.1. Indonesia: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  - 9.5.9.2. Indonesia: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
  - 9.5.9.3. Indonesia: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  - 9.5.9.4. Indonesia: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.5.10. Neurology Clinical Trials Market - South Korea
  - 9.5.10.1. South Korea: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  - 9.5.10.2. South Korea: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
  - 9.5.10.3. South Korea: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  - 9.5.10.4. South Korea: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.5.11. Neurology Clinical Trials Market - Australia
  - 9.5.11.1. Australia: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  - 9.5.11.2. Australia: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
  - 9.5.11.3. Australia: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  - 9.5.11.4. Australia: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.5.12. Neurology Clinical Trials Market - Rest of Asia Pacific
  - 9.5.12.1. Rest of Asia Pacific: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  - 9.5.12.2. Rest of Asia Pacific: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
  - 9.5.12.3. Rest of Asia Pacific: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  - 9.5.12.4. Rest of Asia Pacific: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
9.6. Neurology Clinical Trials Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.6.2. Middle East & Africa: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.6.3. Middle East & Africa: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.6.4. Middle East & Africa: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.6.5. Neurology Clinical Trials Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  - 9.6.5.2. Saudi Arabia: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
  - 9.6.5.3. Saudi Arabia: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  - 9.6.5.4. Saudi Arabia: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.6.6. Neurology Clinical Trials Market - UAE
  - 9.6.6.1. UAE: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  - 9.6.6.2. UAE: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
  - 9.6.6.3. UAE: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  - 9.6.6.4. UAE: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.6.7. Neurology Clinical Trials Market - Israel
  - 9.6.7.1. Israel: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  - 9.6.7.2. Israel: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
  - 9.6.7.3. Israel: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  - 9.6.7.4. Israel: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.6.8. Neurology Clinical Trials Market - South Africa
  - 9.6.8.1. South Africa: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  - 9.6.8.2. South Africa: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
  - 9.6.8.3. South Africa: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  - 9.6.8.4. South Africa: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.6.9. Neurology Clinical Trials Market - Rest of Middle East & Africa
  - 9.6.9.1. Rest of Middle East & Africa: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  - 9.6.9.2. Rest of Middle East & Africa: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
  - 9.6.9.3. Rest of Middle East & Africa: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  - 9.6.9.4. Rest of Middle East & Africa: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
9.7. Neurology Clinical Trials Market - Latin America
- 9.7.1. Latin America: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.7.2. Latin America: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.7.3. Latin America: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.7.4. Latin America: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.7.5. Neurology Clinical Trials Market - Mexico
  - 9.7.5.1. Mexico: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  - 9.7.5.2. Mexico: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
  - 9.7.5.3. Mexico: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  - 9.7.5.4. Mexico: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.7.6. Neurology Clinical Trials Market - Brazil
  - 9.7.6.1. Brazil: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  - 9.7.6.2. Brazil: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
  - 9.7.6.3. Brazil: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  - 9.7.6.4. Brazil: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.7.7. Neurology Clinical Trials Market - Argentina
  - 9.7.7.1. Argentina: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  - 9.7.7.2. Argentina: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
  - 9.7.7.3. Argentina: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  - 9.7.7.4. Argentina: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.7.8. Neurology Clinical Trials Market - Rest of Latin America
  - 9.7.8.1. Rest of Latin America: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  - 9.7.8.2. Rest of Latin America: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
  - 9.7.8.3. Rest of Latin America: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  - 9.7.8.4. Rest of Latin America: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. Biogen
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Charles River Laboratories
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. Eisai Co., Ltd.
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. ICON plc
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. IQVIA
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. Laboratory Corporation of America Holdings
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. Medpace Holdings, Inc.
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. Parexel
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Pfizer Inc.
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Syneos Health
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. Thermo Fisher Scientific
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development

Product Code: PM6420

List of Tables:

Table 1 Global Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
Table 2 Global Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
Table 3 Global Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
Table 4 Global Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
Table 5 North America: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
Table 6 North America: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
Table 7 North America: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
Table 8 North America: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
Table 9 U.S.: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
Table 10 U.S.: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
Table 11 U.S.: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
Table 12 U.S.: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
Table 13 Canada: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
Table 14 Canada: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
Table 15 Canada: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
Table 16 Canada: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
Table 17 Europe: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
Table 18 Europe: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
Table 19 Europe: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
Table 20 Europe: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
Table 21 UK: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
Table 22 UK: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
Table 23 UK: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
Table 24 UK: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
Table 25 France: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
Table 26 France: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
Table 27 France: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
Table 28 France: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
Table 29 Germany: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
Table 30 Germany: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
Table 31 Germany: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
Table 32 Germany: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
Table 33 Italy: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
Table 34 Italy: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
Table 35 Italy: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
Table 36 Italy: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
Table 37 Spain: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
Table 38 Spain: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
Table 39 Spain: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
Table 40 Spain: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
Table 41 Netherlands: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
Table 42 Netherlands: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
Table 43 Netherlands: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
Table 44 Netherlands: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
Table 45 Russia: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
Table 46 Russia: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
Table 47 Russia: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
Table 48 Russia: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
Table 49 Rest of Europe: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
Table 50 Rest of Europe: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
Table 51 Rest of Europe: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
Table 52 Rest of Europe: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
Table 53 Asia Pacific: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
Table 54 Asia Pacific: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
Table 55 Asia Pacific: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
Table 56 Asia Pacific: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
Table 57 China: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
Table 58 China: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
Table 59 China: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
Table 60 China: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
Table 61 India: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
Table 62 India: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
Table 63 India: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
Table 64 India: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
Table 65 Malaysia: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
Table 66 Malaysia: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
Table 67 Malaysia: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
Table 68 Malaysia: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
Table 69 Japan: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
Table 70 Japan: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
Table 71 Japan: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
Table 72 Japan: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
Table 73 Indonesia: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
Table 74 Indonesia: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
Table 75 Indonesia: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
Table 76 Indonesia: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
Table 77 South Korea: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
Table 78 South Korea: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
Table 79 South Korea: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
Table 80 South Korea: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
Table 81 Australia: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
Table 82 Australia: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
Table 83 Australia: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
Table 84 Australia: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
Table 85 Rest of Asia Pacific: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
Table 86 Rest of Asia Pacific: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
Table 87 Rest of Asia Pacific: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
Table 88 Rest of Asia Pacific: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
Table 89 Middle East & Africa: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
Table 90 Middle East & Africa: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
Table 91 Middle East & Africa: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
Table 92 Middle East & Africa: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
Table 93 Saudi Arabia: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
Table 94 Saudi Arabia: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
Table 95 Saudi Arabia: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
Table 96 Saudi Arabia: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
Table 97 UAE: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
Table 98 UAE: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
Table 99 UAE: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
Table 100 UAE: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
Table 101 Israel: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
Table 102 Israel: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
Table 103 Israel: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
Table 104 Israel: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
Table 105 South Africa: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
Table 106 South Africa: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
Table 107 South Africa: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
Table 108 South Africa: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
Table 109 Rest of Middle East & Africa: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
Table 110 Rest of Middle East & Africa: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
Table 111 Rest of Middle East & Africa: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
Table 112 Rest of Middle East & Africa: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
Table 113 Latin America: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
Table 114 Latin America: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
Table 115 Latin America: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
Table 116 Latin America: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
Table 117 Mexico: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
Table 118 Mexico: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
Table 119 Mexico: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
Table 120 Mexico: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
Table 121 Brazil: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
Table 122 Brazil: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
Table 123 Brazil: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
Table 124 Brazil: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
Table 125 Argentina: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
Table 126 Argentina: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
Table 127 Argentina: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
Table 128 Argentina: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
Table 129 Rest of Latin America: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
Table 130 Rest of Latin America: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
Table 131 Rest of Latin America: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
Table 132 Rest of Latin America: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)

List of Figures:

Figure 1. Global Neurology Clinical Trials Market, 2020-2034 (USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Price
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Phase
Figure 7. Global Neurology Clinical Trials Market, by Phase, 2024 & 2034 (USD Billion)
Figure 8. Market by Study Design
Figure 9. Global Neurology Clinical Trials Market, by Study Design, 2024 & 2034 (USD Billion)
Figure 10. Market by Indication
Figure 11. Global Neurology Clinical Trials Market, by Indication, 2024 & 2034 (USD Billion)
Figure 12. Market by Value Chain
Figure 13. Global Neurology Clinical Trials Market, by Value Chain, 2024 & 2034 (USD Billion)